Gapping up
In reaction to strong earnings/guidance: ANF +14.6%, DY +11.1%, EXPR +10.7%, FRO +9.1%, NMBL +8.3%, SLH +4.8%, CEO +4.6%, UPIP +3.9%
M&A news: CAM +45% (to be acquired by Schlumberger (SLB) for ~$66.36/share), EMC +4.5% (EMC Board considering plan where it will be acquired by VMWare (VMW), according to Re Code), VMW +0.6%
Select oil/gas related names showing strength: SDRL +9.5%, CHK +3.5%, BP +3.2%, TOT +2.8%, RDS.A +2.7%
Other news: ABGB +28.3% (cont volatility pre-mkt), OSK +9.3% (announced the U.S. Army has awarded the company a $6.7 bln Joint Light Tactical Vehicle contract), JKS +7.8% (cont volatility pre-mkt), SQNM +7% (entered into clinical research collaboration with the University of California, San Diego Moores Cancer Center), ADXS +6.3% (announces a licensing agreement with Knight Therapeutics to commercialize Advaxis's product portfolio in Canada), SRPT +4.7% (announced the FDA has filed the NDA for eteplirsen for the treatment of Duchenne muscular dystrophy; NDA given priority review with PDUFA date of February 26, 2015), PYPL +2.7% (PayPal One Touch now available across 16 countries), PFE +2.6% (Alvogen announces that it has entered into a definitive agreement with Pfizer, under which it will acquire a portfolio of four pharmaceutical products; terms not disclosed), DIS +2.4% (announces Star Wars 'The Force Awakens' event on YouTube), MGA +1.9% (co obtained an issuer bid exemption order to make private agreement purchases of its common shares from an arm's length third-party seller), TRI+1.8% (to purchase up to 10 mln of its common shares through private agreements with four arm's-length third-party sellers), KNDI +1.7% (still checking), NAT +1.4% (issues letter to shareholders, provides qualitative guidance)
Analyst comments: ARMH +6.4% (upgraded to Mkt Perform from Underperform at Bernstein), NOK +5.8% (upgraded to Buy at Danske Bank ), ERIC +4.8% (upgraded to Hold at Danske Bank), NFLX +4.7% (target raised to $140 from $125 at RBC Capital Mkts), GOOG +4.6% (added to Conviction Buy at Goldman), BHP +4.6% (upgraded to Sector Perform from Underperform at RBC Capital Mkts), RBS +4.5% (upgraded to Overweight at Morgan Stanley), AMZN +3.7% (upgraded to Buy from Hold at Evercore ISI ), NKE +3.2% (upgraded to Positive from Neutral at Susquehanna), BBY +2.9% (upgraded to Strong Buy from Mkt Perform at Raymond James ), IBM +2.5% (upgraded to Buy at Argus), BUD +2% (upgraded to Buy at ING Group), NICE +1.1% (upgraded to Buy from Neutral at UBS), SE +1% (upgraded to Buy at UBS)
In reaction to strong earnings/guidance: ANF +14.6%, DY +11.1%, EXPR +10.7%, FRO +9.1%, NMBL +8.3%, SLH +4.8%, CEO +4.6%, UPIP +3.9%
M&A news: CAM +45% (to be acquired by Schlumberger (SLB) for ~$66.36/share), EMC +4.5% (EMC Board considering plan where it will be acquired by VMWare (VMW), according to Re Code), VMW +0.6%
Select oil/gas related names showing strength: SDRL +9.5%, CHK +3.5%, BP +3.2%, TOT +2.8%, RDS.A +2.7%
Other news: ABGB +28.3% (cont volatility pre-mkt), OSK +9.3% (announced the U.S. Army has awarded the company a $6.7 bln Joint Light Tactical Vehicle contract), JKS +7.8% (cont volatility pre-mkt), SQNM +7% (entered into clinical research collaboration with the University of California, San Diego Moores Cancer Center), ADXS +6.3% (announces a licensing agreement with Knight Therapeutics to commercialize Advaxis's product portfolio in Canada), SRPT +4.7% (announced the FDA has filed the NDA for eteplirsen for the treatment of Duchenne muscular dystrophy; NDA given priority review with PDUFA date of February 26, 2015), PYPL +2.7% (PayPal One Touch now available across 16 countries), PFE +2.6% (Alvogen announces that it has entered into a definitive agreement with Pfizer, under which it will acquire a portfolio of four pharmaceutical products; terms not disclosed), DIS +2.4% (announces Star Wars 'The Force Awakens' event on YouTube), MGA +1.9% (co obtained an issuer bid exemption order to make private agreement purchases of its common shares from an arm's length third-party seller), TRI+1.8% (to purchase up to 10 mln of its common shares through private agreements with four arm's-length third-party sellers), KNDI +1.7% (still checking), NAT +1.4% (issues letter to shareholders, provides qualitative guidance)
Analyst comments: ARMH +6.4% (upgraded to Mkt Perform from Underperform at Bernstein), NOK +5.8% (upgraded to Buy at Danske Bank ), ERIC +4.8% (upgraded to Hold at Danske Bank), NFLX +4.7% (target raised to $140 from $125 at RBC Capital Mkts), GOOG +4.6% (added to Conviction Buy at Goldman), BHP +4.6% (upgraded to Sector Perform from Underperform at RBC Capital Mkts), RBS +4.5% (upgraded to Overweight at Morgan Stanley), AMZN +3.7% (upgraded to Buy from Hold at Evercore ISI ), NKE +3.2% (upgraded to Positive from Neutral at Susquehanna), BBY +2.9% (upgraded to Strong Buy from Mkt Perform at Raymond James ), IBM +2.5% (upgraded to Buy at Argus), BUD +2% (upgraded to Buy at ING Group), NICE +1.1% (upgraded to Buy from Neutral at UBS), SE +1% (upgraded to Buy at UBS)